The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase Ib/II open-label study of tazemetostat (TAZ) plus enzalutamide (E) or abiraterone/prednisone (A/P) in chemotherapy-naive patients (pts) with metastatic castration-resistant prostate cancer (mCRPC).
 
Wassim Abida
Honoraria - CARET
Consulting or Advisory Role - Clovis Oncology; Janssen; MORE Health; ORIC Pharmaceuticals
Research Funding - AstraZeneca (Inst); Clovis Oncology (Inst); GlaxoSmithKline (Inst); Zenith Epigenetics (Inst)
Travel, Accommodations, Expenses - Clovis Oncology; GlaxoSmithKline; ORIC Pharmaceuticals
 
Thomas Paul Bradley
Stock and Other Ownership Interests - Celgene
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb
 
Arash Rezazadeh
Stock and Other Ownership Interests - ECOM Medical
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; EMD Serono; Exelixis; Genentech; Novartis; Pfizer
Speakers' Bureau - Amgen; Astellas Medivation; AstraZeneca; Bristol-Myers Squibb; Eisai; EMD Serono; Exelixis; Exelixis; Genentech/Roche; Janssen; Merck; Novartis; Pfizer; Sanofi
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bavarian Nordic (Inst); Bayer (Inst); BeyondSpring Pharmaceuticals (Inst); BioClin Therapeutics (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Eisai (Inst); Epizyme (Inst); Exelixis (Inst); Genentech (Inst); Immunomedics (Inst); Janssen (Inst); Macrogenics (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Astellas Medivation; AstraZeneca; Bayer; Eisai; Exelixis; Genentech; Janssen; Novartis; Pfizer; Prometheus
 
Lawrence Ivan Karsh
Stock and Other Ownership Interests - Swan Valley Medical (I)
Honoraria - 3D Biopsy; Astellas Pharma; AstraZeneca; Bayer; Boston Scientific; Dendreon; Foundation Medicine; Genomic Health; Janssen; Merck; Myriad Pharmaceuticals; Pfizer; Urogen pharma
Consulting or Advisory Role - 3D Biopsy; Abbvie; Astellas Pharma; Augmenix; Bayer; Dendreon; Ferring; Janssen; Pfizer; Precision Biopsy; Spectrum Pharmaceuticals
Speakers' Bureau - Amgen; Astellas Pharma; AstraZeneca; Bayer; Dendreon; Janssen; Pfizer
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Augmenix (Inst); Bayer (Inst); CU Optics (Inst); Dendreon (Inst); Exact Sciences (Inst); Ferring (Inst); FKD Therapies (Inst); Genomic Health (Inst); Janssen (Inst); Merck (Inst); Myovant Sciences (Inst); Nucleix (Inst); Nymox (Inst); OPKO Biologics (Inst); Pfizer (Inst); Precision Biopsy (Inst); PrecisionMed (Inst); Roche (Inst); Siemens (Inst); Spectrum Pharmaceuticals (Inst); Urogen pharma (Inst); Veru (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Bayer; dendreon; Foundation Medicine; Janssen; Pfizer; Spectrum Pharmaceuticals
 
Ashley Ross
Stock and Other Ownership Interests - GenomeDx
Honoraria - Bayer; Healthtronics
Consulting or Advisory Role - Blue Earth Diagnostics; Healthtronics
Speakers' Bureau - Blue Earth Diagnostics; Johnson & Johnson; Tempus
Research Funding - metamark genetics
 
Daniel Saltzstein
Other Relationship - Epizyme
 
Evren Kocabas Argon
Employment - Epizyme
 
Anthony Hamlett
No Relationships to Disclose
 
Jeanie Tang
Employment - Epizyme
Stock and Other Ownership Interests - Epizyme
Travel, Accommodations, Expenses - Epizyme
 
Deyaa Adib
Employment - Maricel Clinical Consulting
Consulting or Advisory Role - Epizyme
Travel, Accommodations, Expenses - Epizyme